These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16407838)

  • 1. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2006 May; 25(20):2860-72. PubMed ID: 16407838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression.
    Semba S; Huebner K
    Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway.
    Huang Q; Liu Z; Xie F; Liu C; Shao F; Zhu CL; Hu S
    ScientificWorldJournal; 2014; 2014():179698. PubMed ID: 24757411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
    Zhu N; Gu L; Li F; Zhou M
    Mol Cancer Ther; 2008 May; 7(5):1101-9. PubMed ID: 18483299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.
    Roca H; Varsos Z; Pienta KJ
    J Biol Chem; 2008 Sep; 283(36):25057-73. PubMed ID: 18611860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
    Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the role of Fhit in suppression of DNA damage.
    Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
    Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
    Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
    Oncogene; 2015 May; 34(19):2505-15. PubMed ID: 24998847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhit is a physiological target of the protein kinase Src.
    Pekarsky Y; Garrison PN; Palamarchuk A; Zanesi N; Aqeilan RI; Huebner K; Barnes LD; Croce CM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3775-9. PubMed ID: 15007172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
    Zhao P; Meng Q; Liu LZ; You YP; Liu N; Jiang BH
    Biochem Biophys Res Commun; 2010 Apr; 395(2):219-24. PubMed ID: 20361940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of lipoteichoic acid of Bifidobacterium on survivin and its regulatory genes].
    Wang Y; Mai T; Liu MF; Chen SH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):325-8. PubMed ID: 17892124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
    Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
    Yutori H; Semba S; Komori T; Yokozaki H
    Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
    Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
    J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
    Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
    J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.